OpenAlex
PricingAboutJobs
Log inGet started
Work

Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy

HTML

Year: 2008
Type: article
Source: Toxicology
DOI: 10.1016/j.tox.2008.10.011
Authors: Elke Martin, Annemette Vinding Thougaard, Morten Grauslund, Peter B. Jensen, Fredrik Bjorkling, Brian B. Hasinoff, Jette Tjørnelund, Maxwell Sehested, Lars H. Jensen
Institutions: Copenhagen University Hospital, University of Manitoba
Language: English

Topic: Chemotherapy-induced cardiotoxicity and mitigation
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: bisdioxopiperazines, doxorubicin cardiotoxicity, anthracycline-induced cardiomyopathy, cardioprotection, iron chelation, topoisomerase II inhibition, ICRF-187, dexrazoxane, myelosuppression, spontaneously hypertensive rats, cardiomyocytes
SDG: Good health and well-being

Open Access status: closed

Funder: Israel Cancer Research Fund
OpenAlex ID: W1997306293
FWCI: 2.355
Cites: 33
Cited by: 96
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms